Pharmabiz

Contineum Therapeutics phase 2 PIPE-307 VISTA trial to treat RRMS fails to meet its prespecified primary or secondary efficacy endpoints

Contineum Therapeutics phase 2 PIPE-307 VISTA trial to treat RRMS fails to meet its prespecified primary or secondary efficacy endpoints: San Diego Saturday, November 22, 2025, 18 ...
Pharmabiz

Call for expressions of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee

Call for expressions of interest for civil society representatives to participate in the work of EMA’s Paediatric Committee ...
Pharmabiz

Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil as part of first-line regimen in adults with severe acute GvHD refractory to steroids

Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil as part of first-line regimen in adults with severe acute GvHD refractory to steroids: Melbourne, Australia Saturday, No ...
Pharmabiz

BioNxt Solutions receives Eurasian Patent for sublingual cladribine platform

BioNxt Solutions receives Eurasian Patent for sublingual cladribine platform: Vancouver, BC Saturday, November 22, 2025, 17:00 Hrs [IST] BioNxt Solutions Inc. (BioNxt), a bioscien ...
Pharmabiz

Alvotech & Advanz Pharma receive marketing approval across the EEA for Gobivaz, a first-in-market biosimilar to Simponi

Reykjavik, Iceland Saturday, November 22, 2025, 14:00 Hrs [IST] ...
Pharmabiz

iZafe Group inks distribution agreement with Skand to launch of Dosell on the Icelandic market

Zafe Group inks distribution agreement with Skand to launch of Dosell on the Icelandic market: Stockholm Saturday, November 22, 2025, 16:00 Hrs [IST] iZafe Group AB (publ.), a li ...
Pharmabiz

Medical Ventures strengthens Philippine healthcare with advanced MRI centre in Bulacan

Medical Ventures strengthens Philippine healthcare with advanced MRI centre in Bulacan: Our Bureau, Mumbai Saturday, November 22, 2025, 11:00 Hrs [IST] The Province of Bulacan has ...
Pharmabiz

GSK subsidiary, Tesaro initiates litigation against AnaptysBio

GSK subsidiary, Tesaro initiates litigation against AnaptysBio: London UK Saturday, November 22, 2025, 12:00 Hrs [IST] GSK subsidiary, Tesaro, Inc., confirms it has initiated liti ...
Pharmabiz

DGTR issues list of parties regarding bilateral safeguard probe on imports of DOTP, DEHCH from Korea

DGTR issues list of parties regarding bilateral safeguard probe on imports of DOTP, DEHCH from Korea: Shardul Nautiyal, Mumbai Saturday, November 22, 2025, 09:00 Hrs [IST] The Dir ...
Pharmabiz

Karnataka to invest Rs. 600-cr for deeptech; expected to fund AI-pharma as life sciences takes centre-stage

Karnataka to invest Rs. 600-cr for deeptech; expected to fund AI-pharma as life sciences takes centre-stage: Nandita Vijayasimha, Bengaluru Saturday, November 22, 2025, 08:00 Hrs ...
Pharmabiz

Panel of pharmacist bodies contesting APPC election vows Rs. 10 lakh insurance coverage for registered pharmacists

Peethaambaran Kunnathoor, Chennai Saturday, November 22, 2025, 08:00 Hrs [IST] ...
Pharmabiz

NABL issues Guidance document for medical labs to ensure quality of test samples at collection centres

NABL issues Guidance document for medical labs to ensure quality of test samples at collection centres: Shardul Nautiyal, Mumbai Saturday, November 22, 2025, 08:00 Hrs [IST] The N ...